Copy For Citation
UĞAN R. A. , Un H., Gurbuz M. A. , Kaya G., Kahramanlar A., Aksakalli-Magden Z. B. , ...More
LIFE SCIENCES, vol.258, 2020 (Journal Indexed in SCI)
Aim: Omapatrilat is an antagonist of angiotensin-converting (ACE) and neprilysin-neuropeptidase (NEP) enzymes. The aim of our study is to show that omapatrilat may have beneficial effects as a treatment for polymicrobial sepsis.